IMO,
IND submission, FDA approval & ROW deal are the three big ones to look forward to.
They will be the market movers if they go as anticipated.
In the drudge of the interims, the daily grind of price suppression via 'parcel passing' manipulation will drag on relentlessly, save the (hopefully) occasional position taking/accumulation of enlightened investors.
Ann: FDA approval for Phelan-McDermid IND and Phase 2 trial, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.85 |
Change
-0.110(0.85%) |
Mkt cap ! $1.598B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.53 | $6.559M | 511.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1657 | $12.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.85 | 6303 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |